ConductScience.org, home

Paper · 9075798

Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells.

Scott FW and 6 others. Diabetes, 1997. Cited by 80 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells. Papers, record 9075798. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9075798

On this page

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Potential mechanisms by which certain foods promote or inhibit the development of spontaneous diabetes in BB rats: dose, timing, early effect on islet area, and switch in infiltrate from Th1 to Th2 cells.
PubMed
Journal
Diabetes
PubMed
Year
1997
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
80
iCite
Relative citation ratio, by iCite
2
iCite
Revised in PubMed
2019-05-15
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Scott FWF W
2Cloutier HEH E
3Kleemann RR
4Wöerz-Pagenstert UU
5Rowsell PP
6Modler HWH W
7Kolb HH

Source PubMed

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CytokinesMajor topic
Diabetes Mellitus, Type 1Major topic
DietMajor topic
PancreasMajor topic
T-Lymphocytes, Helper-InducerMajor topic
Age Factors
Animals
Disease Models, Animal
Dose-Response Relationship, Drug
Interferon-gamma
Interleukin-10
Rats
Rats, Inbred BB
Th1 Cells
Th2 Cells
Time Factors
Transforming Growth Factor beta

Source PubMed

Grants0

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

None in this release.

Trials0

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

None in this release.

Comments and corrections0

PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.

None in this release.

References0

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

None in this release.

Cited by19

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 80 citations.

PMIDTitleJournalYearIn PapersSource
41,536,244Diet, gut microbiome, and type 1 diabetes: from risk to translational opportunity.Gut Microbes2026https://conductscience.org/library/papers/41536244PubMed
33,803,255Dysbiosis in the Development of Type I Diabetes and Associated Complications: From Mechanisms to Targeted Gut Microbes Manipulation Therapies.Int J Mol Sci2021https://conductscience.org/library/papers/33803255PubMed
32,174,888The Role of Gut Microbiota and Environmental Factors in Type 1 Diabetes Pathogenesis.Front Endocrinol (Lausanne)2020https://conductscience.org/library/papers/32174888PubMed
29,293,587Modulation of the diet and gastrointestinal microbiota normalizes systemic inflammation and β-cell chemokine expression associated with autoimmune diabetes susceptibility.PLoS One2018https://conductscience.org/library/papers/29293587PubMed
24,871,322Dietary gluten and the development of type 1 diabetes.Diabetologia2014https://conductscience.org/library/papers/24871322PubMed
23,349,499Promotion of autoimmune diabetes by cereal diet in the presence or absence of microbes associated with gut immune activation, regulatory imbalance, and altered cathelicidin antimicrobial Peptide.Diabetes2013https://conductscience.org/library/papers/23349499PubMed
22,913,724Dietary gluten alters the balance of pro-inflammatory and anti-inflammatory cytokines in T cells of BALB/c mice.Immunology2013https://conductscience.org/library/papers/22913724PubMed
22,109,896Leaky gut and autoimmune diseases.Clin Rev Allergy Immunol2012https://conductscience.org/library/papers/22109896PubMed
19,538,307Tight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigms.Ann N Y Acad Sci2009https://conductscience.org/library/papers/19538307PubMed
17,682,002Mucosal T-cell immunoregulation varies in early and late inflammatory bowel disease.Gut2007https://conductscience.org/library/papers/17682002PubMed

1 to 10 of 19

See all 19 cited by

Genes0

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

None in this release.

Drugs0

The drugs whose trials, in the Pipelines release, list the paper.

None in this release.

Data0

The data bank entries PubMed's record names. Trial numbers are under Trials.

None in this release.

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/9075798

GET https://conductscience.org/api/papers/v1/9075798/authors